Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999406 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
The expression of CD44v9 may be a new biomarker of malignant potential in muscle invasive UTUC and provide additional prognostic information in patients with UTUC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Masayuki M.D., Eiji M.D., Ph.D., Takeo M.D., Ph.D., Shuji M.D., Ph.D., Hideyuki M.D., Ph.D., Mototsugu M.D., Ph.D.,